Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 116

1.

Modeling for health care and other policy decisions: uses, roles, and validity.

Weinstein MC, Toy EL, Sandberg EA, Neumann PJ, Evans JS, Kuntz KM, Graham JD, Hammitt JK.

Value Health. 2001 Sep-Oct;4(5):348-61.

PMID:
11705125
[PubMed - indexed for MEDLINE]
2.

A third seat at the table: an insider's perspective on patient representatives.

Roth D.

Hastings Cent Rep. 2011 Jan-Feb;41(1):29-31. No abstract available.

PMID:
21329103
[PubMed - indexed for MEDLINE]
3.

Risk management frameworks for human health and environmental risks.

Jardine C, Hrudey S, Shortreed J, Craig L, Krewski D, Furgal C, McColl S.

J Toxicol Environ Health B Crit Rev. 2003 Nov-Dec;6(6):569-720. Review.

PMID:
14698953
[PubMed - indexed for MEDLINE]
4.

Role of technology assessment in health benefits coverage for medical devices.

Braslow NM, Shatin D, McCarthy DB, Newcomer LN.

Am J Manag Care. 1998 Sep 25;4 Spec No:SP139-50.

PMID:
10185990
[PubMed - indexed for MEDLINE]
Free Article
5.

Regulation of health-related technologies in Germany.

Perleth M, Busse R, Schwartz FW.

Health Policy. 1999 Jan;46(2):105-26.

PMID:
10346284
[PubMed - indexed for MEDLINE]
6.

Reflections on science, judgment, and value in evidence-based decision making: a conversation with David Eddy by Sean R. Tunis.

Eddy D.

Health Aff (Millwood). 2007 Jul-Aug;26(4):w500-15. Epub 2007 Jun 19.

PMID:
17580317
[PubMed - indexed for MEDLINE]
Free Article
7.

Regulating the economic evaluation of pharmaceuticals and medical devices: a European perspective.

Cookson R, Hutton J.

Health Policy. 2003 Feb;63(2):167-78.

PMID:
12543529
[PubMed - indexed for MEDLINE]
8.

Economic evaluation of diagnostic technology. Methodological challenges and viable solutions.

Sassi F, McKee M, Roberts JA.

Int J Technol Assess Health Care. 1997 Fall;13(4):613-30. Review.

PMID:
9489253
[PubMed - indexed for MEDLINE]
9.

Insurance coverage for experimental technologies.

Steinberg EP, Tunis S, Shapiro D.

Health Aff (Millwood). 1995 Winter;14(4):143-58.

PMID:
8690340
[PubMed - indexed for MEDLINE]
Free Article
10.

Challenges ahead for federal technology assessment.

Neumann PJ.

Health Aff (Millwood). 2007 Mar-Apr;26(2):w150-2. Epub 2007 Jan 26. Review.

PMID:
17259197
[PubMed - indexed for MEDLINE]
Free Article
11.

Regulating biotechnology: a rational-political model of policy development.

Wiktorowicz M, Deber R.

Health Policy. 1997 May;40(2):115-38. Erratum in: Health Policy 1997 Jun;40(3):271.

PMID:
10167067
[PubMed - indexed for MEDLINE]
12.

Technology assessment and coverage decision making.

McGivney WT.

AAPPO J. 1994 Sep-Oct;4(5):11-2, 14-7.

PMID:
10150666
[PubMed - indexed for MEDLINE]
13.

Comparison of anticancer drug coverage decisions in the United States and United Kingdom: does the evidence support the rhetoric?

Mason A, Drummond M, Ramsey S, Campbell J, Raisch D.

J Clin Oncol. 2010 Jul 10;28(20):3234-8. doi: 10.1200/JCO.2009.26.2758. Epub 2010 May 24.

PMID:
20498408
[PubMed - indexed for MEDLINE]
Free Article
14.

A changing paradigm in the study and adoption of emerging health care technologies: coverage with evidence development.

Wallner PE, Konski A.

J Am Coll Radiol. 2008 Nov;5(11):1125-9. doi: 10.1016/j.jacr.2008.06.008. Review.

PMID:
18954812
[PubMed - indexed for MEDLINE]
15.
16.
17.

A review of quantitative risk-benefit methodologies for assessing drug safety and efficacy-report of the ISPOR risk-benefit management working group.

Guo JJ, Pandey S, Doyle J, Bian B, Lis Y, Raisch DW.

Value Health. 2010 Aug;13(5):657-66. doi: 10.1111/j.1524-4733.2010.00725.x. Epub 2010 Apr 15. Review.

PMID:
20412543
[PubMed - indexed for MEDLINE]
18.

Methods for determining cost-benefit ratios for pharmaceuticals in Germany.

von der Schulenburg J, Vauth C, Mittendorf T, Greiner W.

Eur J Health Econ. 2007 Sep;8 Suppl 1:S5-31. Review.

PMID:
17582539
[PubMed - indexed for MEDLINE]
19.

Food safety: risk assessment methodology and decision-making criteria.

Brock WJ, Rodricks JV, Rulis A, Dellarco VL, Gray GM, Lane RW.

Int J Toxicol. 2003 Nov-Dec;22(6):435-51.

PMID:
14680991
[PubMed - indexed for MEDLINE]
20.

Evidence, appropriateness, and technology assessment in cardiology: a case study of computed tomography.

Redberg RF.

Health Aff (Millwood). 2007 Jan-Feb;26(1):86-95.

PMID:
17211017
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk